Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Coffee Holding Co
JVA
$20.2M
| $748K | ﹤0.01% |
168,400
+20,100
| +14% | +$83.9K |
|
|
STAB
2677
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $747K | ﹤0.01% |
217,016
+24,300
| +13% | +$68.8K |
|
2678
Colony Bankcorp
CBAN
$467M
| $743K | ﹤0.01% |
54,000
+1,200
| +2% | +$16.3K |
|
|
CBMX
2679
DELISTED
CombiMatrix Corporation
CBMX
| $743K | ﹤0.01% |
99,100
+83,391
| +531% | +$566K |
|
|
LOAN
2680
Manhattan Bridge Capital
LOAN
$47.2M
| $742K | ﹤0.01% |
126,800
-24,200
| -16% | -$137K |
|
2681
Alphatec Holdings
ATEC
$1.49B
| $736K | ﹤0.01% |
325,787
+8,600
| +3% | +$16.6K |
|
2682
Willamette Valley Vineyards
WVVI
$12M
| $732K | ﹤0.01% |
92,500
+12,100
| +15% | +$96.7K |
|
2683
Mitek Systems
MITK
$838M
| $730K | ﹤0.01% |
76,799
-677
| -0.9% | -$6.61K |
|
2684
Hennessy Advisors
HNNA
$78.9M
| $728K | ﹤0.01% |
47,175
-4,175
| -8% | -$64.5K |
|
|
ESPR
2685
DELISTED
Esperion Therapeutics
ESPR
| $727K | ﹤0.01% |
+14,500
| New | +$699K |
|
2686
CPI Aerostructures
CVU
$75M
| $726K | ﹤0.01% |
77,625
-7,675
| -9% | -$69.5K |
|
|
NOAH
2687
Noah Holdings
NOAH
$588M
| $726K | ﹤0.01% |
+22,600
| New | +$690K |
|
2688
Veru
VERU
$46M
| $726K | ﹤0.01% |
27,400
-5,130
| -16% | -$75.1K |
|
|
ASBB
2689
DELISTED
ASB Bancorp Inc
ASBB
| $726K | ﹤0.01% |
16,100
+4,200
| +35% | +$185K |
|
|
DMTX
2690
DELISTED
Dimension Therapeutics, Inc
DMTX
| $726K | ﹤0.01% |
121,000
+32,700
| +37% | +$84.8K |
|
2691
Henry Schein
HSIC
$10.1B
| $722K | ﹤0.01% |
11,235
-159,885
| -93% | -$10.9M |
|
2692
Indaptus Therapeutics
INDP
$141M
| $720K | ﹤0.01% |
36
+24
| +200% | +$346K |
|
2693
Columbia Sportswear
COLM
$2.88B
| $714K | ﹤0.01% |
11,600
-88,302
| -88% | -$5.12M |
|
|
OPOF
2694
DELISTED
Old Point Financial
OPOF
| $713K | ﹤0.01% |
22,000
+8,500
| +63% | +$269K |
|
|
SRLP
2695
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $713K | ﹤0.01% |
+29,000
| New | +$764K |
|
|
SJT
2696
San Juan Basin Royalty Trust
SJT
$131M
| $712K | ﹤0.01% |
+90,825
| New | +$637K |
|
2697
eGain
EGAN
$200M
| $711K | ﹤0.01% |
263,230
+116,530
| +79% | +$227K |
|
|
VRTV
2698
DELISTED
VERITIV CORPORATION
VRTV
| $709K | ﹤0.01% |
21,800
-37,700
| -63% | -$1.26M |
|
2699
HCI Group
HCI
$2.28B
| $704K | ﹤0.01% |
+18,396
| New | +$755K |
|
|
GST
2700
DELISTED
Gastar Exploration Inc.
GST
| $701K | ﹤0.01% |
796,574
-944,300
| -54% | -$704K |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.